Radu Dobrin
About Radu Dobrin
Radu Dobrin is the Executive Director, Head of Bioinformatics Immunology & Oncology, TRCs and Early Development at Bristol Myers Squibb, and an Adjunct Associate Professor at Mount Sinai School of Medicine.
Current Role at Bristol Myers Squibb
Radu Dobrin serves as the Executive Director, Head of Bioinformatics Immunology & Oncology, TRCs and Early Development at Bristol Myers Squibb in Princeton, New Jersey. In his role, he focuses on leveraging bioinformatics to advance research in immunology and oncology. He combines patient and drug data with robust machine learning (ML) and artificial intelligence (AI) algorithms, as well as intuitive visualization platforms, to drive innovation in early-stage drug development.
Previous Experience at Bristol Myers Squibb
Prior to his current role, Radu Dobrin worked as the Director, Head of Immuno-Oncology Translational Bioinformatics at Bristol Myers Squibb from 2017 to 2020. During this period, he was involved in utilizing bioinformatics tools and data analytics to advance translational research in immuno-oncology, playing a key role in bridging the gap between laboratory research and clinical application.
Role at Mount Sinai School of Medicine
In addition to his industry positions, Radu Dobrin currently holds the role of Adjunct Associate Professor at Mount Sinai School of Medicine in the Greater New York City Area. His academic role allows him to contribute to educational initiatives and research in the field of bioinformatics and biostatistics, sharing his industry expertise with the next generation of scientists.
Educational Background
Radu Dobrin has a strong educational foundation, starting with a Bachelor's degree in Physics from Universitatea ‚Babeș-Bolyai’ din Cluj-Napoca, followed by a Master’s degree in the same field. He furthered his education at Michigan State University, where he earned a Master of Science in Computer Engineering and a Ph.D. in Physics of Disordered Media. His advanced academic background has equipped him with the knowledge necessary for his research and professional activities in bioinformatics and oncology.
Previous Roles and Experience
Throughout his career, Radu Dobrin has held several key positions in major pharmaceutical companies. He served as Associate Director and Principal Scientist at Johnson & Johnson, as well as a Research Fellow at Merck. Additionally, he was a Senior Research Scientist at Rosetta Inpharmatics and a Professional Research Associate at Princeton University. His roles have consistently involved the application of bioinformatics and data analytics to drive pharmaceutical research and development.